- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Systemic Sclerosis in United States
Total 75406 results
-
Barnes Retina InstituteCompletedNuclear Sclerotic CataractUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedSubjects With Severe, Refractory Sclerotic Skin ChangesUnited States
-
Genentech, Inc.CompletedMultiple Sclerosis, Primary Progressive | Relapsing Multiple SclerorsisUnited States, Germany, Canada, Sweden
-
UMC UtrechtBoehringer Ingelheim; ZonMw: The Netherlands Organisation for Health Research... and other collaboratorsRecruitingSystemic Sclerosis | Scleroderma, Diffuse | Mycophenolate Mofetil | Scleroderma | Autologous Stem Cell Transplantation | Cyclophosphamide | Systemic Scleroses, Diffuse | Treatment StrategyItaly, Switzerland, Netherlands, Sweden, United Kingdom
-
National Cancer Institute (NCI)CompletedSclerotic Graft Versus Host Disease | Imatinib MesylateUnited States
-
Michael M. PhamTerminatedSystemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditionsUnited States
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of South FloridaGenentech, Inc.Active, not recruitingPathologic Processes | Nervous System Diseases | Immune System Diseases | Multiple Sclerosis | Demyelinating Diseases | Autoimmune Diseases | Relapsing Remitting Multiple Sclerosis | Primary Progressive Multiple SclerosisUnited States
-
Johns Hopkins UniversityCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Rebecca SpainCompletedComparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple SclerosisProgressive Multiple Sclerosis | Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Boston UniversityCompleted
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more
-
Johns Hopkins UniversityUnited States Department of DefenseCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Johns Hopkins UniversityCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
University of LouisvilleBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Relapsing-remittingUnited States
-
Hospital for Special Surgery, New YorkHuman Genome Sciences Inc.CompletedSystemic SclerosisUnited States
-
Boston UniversityAspreva PharmaceuticalsCompleted
-
Thomas Jefferson UniversityRecruitingRelapse Remitting Multiple SclerosisUnited States
-
Waukesha Memorial HospitalThe Cleveland ClinicCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Hospital for Special Surgery, New YorkGlaxoSmithKlineRecruitingSystemic SclerosisUnited States
-
University of PennsylvaniaGilead SciencesCompletedSystemic Sclerosis | SclerodermaUnited States
-
Ohio State UniversityNational Multiple Sclerosis SocietyCompleted
-
NeurognosticsCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Talaris Therapeutics Inc.WithdrawnDiffuse Cutaneous Systemic SclerosisUnited States
-
University of California, Los AngelesRecruitingPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi CompanyCompletedSecondary Progressive Multiple SclerosisUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Fred Hutchinson Cancer CenterNational Institute of Allergy and Infectious Diseases (NIAID)CompletedSystemic Scleroderma | Severe Systemic SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States
-
EMD SeronoPfizerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)United States
-
Providence Multiple Sclerosis CenterBiogenCompletedClinically Isolated Syndrome | Relapsing-remitting Multiple SclerosisUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
University of North Carolina, Chapel HillGenzyme, a Sanofi CompanyTerminatedRELAPSING REMITTING MULTIPLE SCLEROSISUnited States
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
Boston UniversityRegeneron PharmaceuticalsCompletedSystemic Sclerosis | Scleroderma | Diffuse Systemic Sclerosis | Diffuse SclerodermaUnited States
-
Kessler FoundationActive, not recruitingMultiple Sclerosis | Relapsing-remitting Multiple SclerosisUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
Opexa Therapeutics, Inc.CompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
MSDx, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States
-
OhioHealthCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Revalesio CorporationWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
University of Wisconsin, MadisonCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Alabama Neurology Associates, PCBiogenUnknownRelapsing Remitting Multiple SclerosisUnited States
-
Multiple Sclerosis InstituteUnknown
-
University of LouisvilleRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Johns Hopkins UniversityGlaxoSmithKlineTerminatedMultiple SclerosisUnited States